Cargando…
含10天地西他滨预处理方案异基因造血干细胞移植治疗31例急性髓系白血病/骨髓增生异常综合征患者的疗效及安全性
OBJECTIVE: To investigate the early effect and safety of allogeneic hematopoietic stem cell transplantation(allo-HSCT)with a 10-day decitabine-containing conditioning regimen in the treatment of acute myeloid leukemia(AML)/myelodysplastic syndrome (MDS). METHODS: From April 2021 to May 2022, 31 AML/...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450562/ https://www.ncbi.nlm.nih.gov/pubmed/37550202 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.06.005 |
Ejemplares similares
-
含地西他滨预处理方案异基因造血干细胞移植治疗骨髓增生异常综合征/慢性粒-单核细胞白血病的疗效及安全性
Publicado: (2019) -
地西他滨治疗骨髓增生异常综合征及相关肿瘤的疗效预测因素研究
Publicado: (2017) -
地西他滨桥接异基因造血干细胞移植治疗骨髓增生异常综合征的疗效分析
Publicado: (2015) -
地西他滨联合半量CAG方案治疗骨髓增生异常综合征伴原始细胞增多和急性髓系白血病伴骨髓增生异常相关改变
Publicado: (2018) -
小剂量地西他滨治疗较低危骨髓增生异常综合征患者疗效初步观察
Publicado: (2017)